BrainFx is partnering with scientists in cannabis research and driving simulation at Apollo Applied Research and Toronto Rehabilitation Institute (UHN) to validate BrainFx DRIVE Screen for roadside use.
Interface Biologics Announces New V.P., Business Development
OBIO 2018 Annual General Meeting: Recap and Photo Gallery
On November 28th, OBIO held our 2018 Annual General Meeting at the offices of Norton Rose Fulbright. The exciting event featured Nik Nanos, our keynote speaker whose presentation Global Disruption: How to Make Decisions in an Age When Truth and Data are No Longer Enough to Persuade scanned recent global political experiences and explained the outsized influence of the margins, both on electoral outcomes as well as the impact for your company.
Eve Medical and Tickit Health Named 2018 SheEO Venture Semi-Finalists
Reviewing ‘Talking to Doctors and Patients: Using Primary Market Research Data to Seal the Deal with Investors’
Reviewing ‘Doing Deals with Strategics & Investors: Getting on Their Radar and Staying There’
Looking to Hire in January? New Funding Source Available
Synaptive Medical Featured in Excellence in Care Award
Hour Detroit Magazine presented Henry Ford Health System with an Excellence in Care Award for patient treatment using Synaptive Medical's technology.
Researchers Predict Changes in Pain for Users of ManagingLife’s App
Thornhill Research Wins Emerging Exporter Award at the Ontario Export Awards
Apply for Ontario Brain Institute’s GEEK Program
Recapping the OBIO Canadian Health Investment Showcase in New York City: Photo Gallery
KA Imaging Partnership with Grand River Hospital Featured on CTV News
Rna Diagnostics Announces $5M Series A Financing Round Led by iGAN Partners
OBIO Completes Successful Canadian Health Investment Showcase in New York City
ExVivo Labs, ProteinQure and iBionics Accepted to Canadian Technology Accelerator San Francisco
Thornhill Medical Named Finalist at the 2018 Ontario Export Awards
Conavi Medical Awarded Joule Innovation Grant
Focal Healthcare Announces FDA and Health Canada Clearance
OBIO Opens Canadian Health Investment Showcase in New York City, Connecting Canada’s High Potential Health Science Companies with Premier US Investors
The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce the opening of the Canadian Health Investment Showcase in New York, NY, on November 5 and 6, 2018.
The Canadian Health Investment Showcase will feature 18 of Canada’s highest potential companies meeting with more than 35 US investors and VCs in New York City to drive investment in Canada’s health science industry.
Over two days at the Consulate General of Canada in New York, the Canadian Health Investment Showcase features hundreds of one-on-one meetings between companies and US investors, as well as panel discussions on cross-border investing in the health science industry and a keynote on trends in health investing this year.
To find out more, click here to read the full press release.